跳转至内容
Merck
CN

MAK115

Sigma-Aldrich

血红蛋白测定试剂盒

sufficient for 250 colorimetric tests

别名:

Hemoglobin Quantitation Kit

登录查看公司和协议定价


About This Item

UNSPSC代码:
12161503
NACRES:
NA.84

用途

sufficient for 250 colorimetric tests

检测方法

colorimetric

相关疾病

hematological disorder

储存温度

2-8°C

基因信息

一般描述

血红蛋白(Hb)适应含铁金属蛋白质,是脊椎动物中氧气传递的主要方式。血红蛋白主要在红血细胞中它构成了细胞′s97%的干重。血红细胞还会存在在其他组织中,作为抗氧化剂。多种疾病,比如贫血和多细胞血症,会改变血液中血红细胞水平。

应用

血红细胞分析试剂盒可以用来检测血红细胞浓度。

特点和优势

兼容高通量的操作系统。 可在比色皿中使用。

适用性

适于检测血液、血清、血浆和尿液等多种样品中的血红蛋白成分。 本试剂盒可用于研究各类化合物对血红蛋白代谢和表达水平的调控作用。

原理

该分析是根据改进Triton[NP1]/NaOH方法,血红细胞被转化成比色产物,在400nm测量。该分析在96孔板分析中检测范围为 0.9-200 mg/dL。

法律信息

Triton is a trademark of The Dow Chemical Company or an affiliated company of Dow

象形图

CorrosionEnvironment

警示用语:

Warning

危险声明

危险分类

Aquatic Acute 1 - Aquatic Chronic 2 - Eye Irrit. 2 - Met. Corr. 1

储存分类代码

8B - Non-combustible corrosive hazardous materials


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Malthe Hvas et al.
Conservation physiology, 5(1), cox066-cox066 (2017-12-09)
The parasitic amoeba Paramoeba perurans is an aetiological agent of amoebic gill disease (AGD), a serious problem in seawater salmonid aquaculture globally. Other finfish species are also infected and infection events may be associated with periods of unusual high temperatures.
M J Faulkner et al.
Journal of dairy science, 100(7), 5368-5377 (2017-05-01)
Eighteen multiparous cows were used in a split-plot replicated Latin square with two 28-d periods to evaluate the effects of source of supplemental Cu, Zn, and Mn (sulfates or hydroxy) on apparent absorption of minerals when fed in either a
Polycythemia vera masked due to severe iron deficiency anemia.
Kambali S and Asma T
Hematology/oncology and Stem Cell Therapy (2016)
Biochemical markers of oxidative stress in Saudi women with recurrent miscarriage.
Ghneim H K and Mashael M A
Journal of Korean Medical Science, 31(1), 98-105 (2016)
Heechun Kwak et al.
Research and practice in thrombosis and haemostasis, 4(8), 1301-1312 (2020-12-15)
Replacement therapy is the most common treatment for reduction of bleeding and control of episodic bleeding in individuals with hemophilia. Despite the proven effectiveness of factor replacement therapy, repeated intravenous administration is a heavy burden to individuals with hemophilia. To

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门